Zoloft®—also known as sertraline—is an antidepressant medication belonging to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). It’s designed to treat psychological conditions such as major depressive disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and general anxiety disorder.
The New England Journal of Medicine reported that taking SSRIs like Zoloft during pregnancy may put babies at higher risk of developing birth defects. The Zoloft injury lawyers at Ferrer, Poirot & Wansbrough are here to help if you took Zoloft and your child was born with birth defects. Don’t wait to get the help you need—call us now at (800) 210-8503 or fill out a free initial consultation form.
Birth Defects from Zoloft® Use
According to a report by the U.S. Food and Drug Administration, babies exposed to SSRIs like Zoloft while in the womb may be born with certain birth defects, such as:
- Persistent Pulmonary Hypertension (PPHN)
PPHN is characterized by problems in babies’ circulatory systems that affect the amount of oxygen supplied to the bloodstream. Babies with this condition who aren’t treated right away may suffer heart failure, seizures, organ damage, and even death.
This condition refers to the growth of babies’ organs outside their bodies. Children who are affected by this condition may have heart defects and require immediate surgery to place the organs inside the abdominal cavities.
The surgeries to treat these conditions can be expensive. At Ferrer, Poirot & Wansbrough, it’s our goal to help innocent victims and their families get the money they need to cover the costs of treatments after suffering SSRI-related birth defects.
We’ll Fight for Your Rights
Don’t suffer because you were prescribed a drug that was harmful to your baby. Let our drug injury lawyers build a strong claim for you. We’ll stand up to the drug manufacturer and the insurance company to help you get the compensation you deserve.
Zoloft® is a registered trademark of Pfizer Inc.
This law firm is not associated with, sponsored by, or affiliated with Pfizer Inc., The New England Journal of Medicine, or the U.S. Food and Drug Administration.